VERSAPEUTICS INC
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.9Mattributed |
|---|---|
| Latest round | grant, $2.9M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | SAN DIEGO, California |
| Industry | unknown |
| Stage | unknown |
| Website | versapeutics.com |
Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatment
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $2.9M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.9M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.9M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | versapeutics.com, read 2026-05-07 |
| Description | self-reported | versapeutics.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.